Design and synthesis of the CB1 selective cannabinoid antagonist AM281: A potential human SPECT ligand
- 20 June 1999
- journal article
- Published by Springer Nature in AAPS PharmSci
- Vol. 1 (2) , 39-45
Abstract
In the search for a radioligand capable of imaging cannabinoid CB1 receptors in the living human brain by SPECT (single photon emission computed tomography), N-(morpholin-4-yl)-1-(2,4-dichlorophenyl)-...Keywords
This publication has 24 references indexed in Scilit:
- Classical/Nonclassical Hybrid Cannabinoids: Southern Aliphatic Chain-Functionalized C-6β Methyl, Ethyl, and Propyl AnaloguesJournal of Medicinal Chemistry, 1998
- Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptorsLife Sciences, 1997
- Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea‐pig myenteric plexusBritish Journal of Pharmacology, 1997
- Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brainLife Sciences, 1996
- Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonistLife Sciences, 1995
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Electrophilic destannylation: stereospecific introduction of electrophiles at the 21 position of (17.alpha.)-19-norpregna-1,3,5(10),20-tetraene-3,17.beta.-diolsThe Journal of Organic Chemistry, 1987
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973